MRTX
Mirati Therapeutics Inc
Price:  
58.70 
USD
Volume:  
20,954,800.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRTX Probability of Bankruptcy

The Probability of Bankruptcy of Mirati Therapeutics Inc (MRTX) is 76.67% . This number represents the probability that MRTX will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating MRTX's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

MRTX - ESG ratings

ESG ratings are directly linked to the cost of capital and MRTX's ability to raise funding, both of which can significantly affect the probability of Mirati Therapeutics Inc going bankrupt.

ESG Score 75.26
Environment Score 85.72
Social Score 99.00
Governance Score 41.06
Returns
Historical Returns (5 day) -0.47%
Historical Returns (MTD) -0.09%
Historical Returns (YTD) -0.09%
Historical Returns (13 week) 4.36%
Historical Returns (26 week) 47.69%
Historical Returns (52 week) -40.74%
Efficiency
Asset Turnover 0.04
Receiveable Turnover 15.75
Gross Margin 89.70%
Operating Margin -1,049.09%
Pretax Margin -987.20%
Net Margin -987.20%
Return on Asset (ROA) -67.82
Return on Equity (ROE) -82.15
Return on Investments (ROI) -82.15
Price Metrics
Market Cap (M) 4,117.81
Enterprise Value (M)
52 Week High 59.46
52 Week Low 56.31
Beta -0.29
Average Volume (10 day) 3.42
Average Volume (3 month) 2.25
Price / Earnings (P/E)
Price / Sales (P/S) 107.82
Earnings
EPS -12.22
Revenue CAGR (5 year) 31.78%
Risk
Current Ratio 7.54
Quick Ratio 7.25